The effects of blood pressure control levels on the renoprotection of type 2 diabetic patients without overt proteinuria

Journal of the American Society of Hypertension

Volumn 6, Issue 2, 2012, Pages 124-131

  Uzu, Takashi ^a   Kida, Yasuo ^b   Yamauchi, Atsushi ^c   Kume, Shinji ^a   Isshiki, Keiji ^a   Araki, Shin Ichi ^a   Koya, Daisuke ^d   Haneda, Masakazu ^e   Kashiwagi, Atsunori ^a   Maegawa, Hiroshi ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Second Okamoto Hospital   (Japan)

^c OSAKA ROSAI HOSPITAL   (Japan)

^d KANAZAWA MEDICAL UNIVERSITY   (Japan)

^e ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Albuminuria; cerebral infarction; kidney; renal prognosis

Indexed keywords

CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPANESE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERT PROTEINURIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; RENAL PROTECTION; SILENT CEREBRAL INFARCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BLOOD PRESSURE; CEREBRAL INFARCTION; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; RISK FACTORS;

EID: 84858702127     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2011.11.001     Document Type: Article

References (32)

1. A.I. Adler, R.J. Stevens, S.E. Manley, R.W. Bilous, C.A. Cull, and R.R. Holman Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 2003 225 232 (Pubitemid 35463925)
2. G.L. Bakris, M. Williams, L. Dworkin, W.J. Elliott, M. Epstein, and R. Toto Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kidney Dis 36 2000 646 661
3. M.J. Klag, P.K. Whelton, B.L. Randall, J.D. Neaton, F.L. Brancati, and J. Stamler End-stage renal disease in African-American and white men. 16-year MRFIT findings JAMA 277 1997 1293 1298 (Pubitemid 27194353)
4. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
5. G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, and G. Germano 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 25 2007 1105 1187 (Pubitemid 46924065)
6. Kidney Disease Outcomes Quality Initiative (K/DOQI) K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease Am J Kidney Dis 43 Suppl 1 2004 S1 S290
7. T. Ogihara, K. Kikuchi, H. Matsuoka, T. Fujita, J. Higaki, and M. Horiuchi The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) Hypertens Res 32 2009 3 107
8. D. Harris, M. Thomas, D. Johnson, K. Nicholls, and A. Gillin The CARI guidelines. Prevention of progression of kidney disease Nephrology (Carlton) 11 Suppl 1 2006 S2 S197
9. M.J. Sarnak, T. Greene, X. Wang, G. Beck, J.W. Kusek, and A.J. Collins The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study Ann Intern Med 142 2005 342 351 (Pubitemid 40293407)
10. L.J. Appel, J.T. Wright Jr, T. Greene, L.Y. Agodoa, B.C. Astor, and G.L. Bakris Intensive blood-pressure control in hypertensive chronic kidney disease N Engl J Med 363 2010 918 929
11. A. Upadhyay, A. Earley, S.M. Haynes, and K. Uhlig Blood pressure target in chronic kidney disease and proteinuria as an effect modifier Ann Intern Med 154 2011 541 548
12. P. Sleight, J. Redon, P. Verdecchia, G. Mancia, P. Gao, and R. Fagard Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study J Hypertens 27 2009 1360 1369
13. W.C. Cushman, G.W. Evans, R.P. Byington, D.C. Goff Jr, R.H. Grimm Jr, and J.A. Cutler Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med 362 2010 1575 1585
14. R.J. MacIsaac, S. Panagiotopoulos, K.J. McNeil, T.J. Smith, C. Tsalamandris, and H. Hao Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease? Diabetes Care 29 2006 1560 1566 (Pubitemid 44127581)
15. K. Nakao, T. Uzu, S. Araki, S. Kume, N. Deji, and M.C. Kanasaki Arterial stiffness and renal impairment in non-proteinuric type 2 diabetic patients J Diabetes Invest 2011 [Epub ahead of print]
16. P. Fioretto, and M. Mauer Histopathology of diabetic nephropathy Semin Nephrol 27 2007 195 207 (Pubitemid 46550314)
17. T. Uzu, Y. Kida, N. Shirahashi, T. Harada, A. Yamauchi, and M. Nomura Cerebral microvascular disease predicts renal failure in type 2 diabetes J Am Soc Nephrol 21 2010 520 526
18. M.F. O'Rourke, and M.E. Safar Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy Hypertension 46 2005 200 204 (Pubitemid 40946514)
19. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, and K. Nitta Revised equations for estimating glomerular filtration rate (GFR) from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
20. Y. Seino, K. Nanjo, N. Tajima, T. Kadowaki, A. Kashiwagi, and E. Araki Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus J Diabetes Investig 1 2010 212 228
21. J.T. Wright Jr., G. Bakris, T. Greene, L.Y. Agodoa, L.J. Appel, and J. Charleston Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial JAMA 288 2002 2421 2431 (Pubitemid 35340538)
22. R.D. Toto, H.C. Mitchell, R.D. Smith, H.C. Lee, D. McIntire, and W.A. Pettinger "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis Kidney Int 48 1995 851 859
23. J.B. Lewis, T. Berl, R.P. Bain, R.D. Rohde, and E.J. Lewis Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group Am J Kidney Dis 34 1999 809 817 (Pubitemid 29521695)
24. P. Ruggenenti, A. Perna, G. Loriga, M. Ganeva, B. Ene-Iordache, and M. Turturro Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial Lancet 365 2005 939 946 (Pubitemid 41071427)
25. S. Klahr, A.S. Levey, G.J. Beck, A.W. Caggiula, and L. Hunsicker The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 1994 877 884 (Pubitemid 24094966)
26. C.P. Kovesdy, B.K. Trivedi, K. Kalantar-Zadeh, and J.E. Anderson Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease Nephrol Dial Transplant 21 2006 1257 1262
27. M. Nangaku Chronic Hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure J Am Soc Nephrol 17 2006 17 25
28. S. Bangalore, S. Kumar, I. Lobach, and F.H. Messerli Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials Circulation 123 2011 2799 2810
29. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 2008 580 591 (Pubitemid 351214285)
30. B.A. Perkins, L.H. Ficociello, K.H. Silva, D.M. Finkelstein, J.H. Warram, and A.S. Krolewski Regression of microalbuminuria in type 1 diabetes N Engl J Med 348 2003 2285 2293 (Pubitemid 36638102)
31. S. Araki, M. Haneda, T. Sugimoto, M. Isono, K. Isshiki, and A. Kashiwagi Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes Diabetes 54 2005 2983 2987 (Pubitemid 41401096)
32. S. Araki, M. Haneda, D. Koya, A. Kashiwagi, T. Uzu, and R. Kikkawa Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus Diabetes Res Clin Pract Suppl 1 2008 S54 S58